During a live event, participating oncologists discuss the role of ctDNA and molecular testing in muscle-invasive bladder ...

The following is a summary of “GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis,” published in the February 2025 ...

Discover recent findings that highlight the potential for urinary DNA methylation testing to improve early detection and diagnosis of bladder cancer.

Gene's lead asset shows high complete response rates in BCG-unresponsive NMIBC patients. Click here to read why ENGN stock is ...

This week’s Bulls N’ Bears ASX Runner of the Week is… Wide Open Agriculture. The company surged on news its high-protein ...

Nick Slowik was rocked by stage 4 prostate cancer diagnosis. But after surgery, local high school basketball official returned to court.

Over the last years, many biological markers emerged that act as an adjunct for the detection of early bladder cancer recurrence. Some of these markers had a proven better sensitivity and ...

New AUA microhematuria guideline incorporates language for urine-based biomarkers in appropriately counseled ...

FDA approves vimseltinib for tenosynovial giant cell tumor and a triplet for R/R LBCL, plus the latest from ASCO GU 2025.

The market for PDTs in oncology is projected to experience substantial growth in the coming years. This growth is driven by a rising number of patien ...